| PERIOD ENDING | 30-Apr-09 | 30-Apr-08 | 30-Apr-07 | | Total Revenue | 128 | 704 | 236 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 128 | 704 | 236 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 3,825 | 7,807 | 4,950 | | Non Recurring | 54,339 | 7,882 |
-
| | Others | 121 | 252 | 11 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (58,157) | (15,238) | (4,725) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,488 | (1,577) | (11,468) | | Earnings Before Interest And Taxes | (30,726) | (16,815) | (6,139) | | Interest Expense | 12 | 2,364 | 38 | | Income Before Tax | (30,738) | (19,179) | (6,177) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (56,681) | (19,179) | (16,231) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (56,681) | (19,179) | (16,231) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($56,681) | ($19,179) | ($16,231) |
|
0.20% Nasdaq 0.00%
Income Statement
